HIV resistance to lenacapavir weakens the virus's ability to replicate

Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with ...

Study finds preventive HIV drugs are under prescribed to young women at increased risk

Although adolescents and young adults comprise only one quarter of the sexually active population in the United States, approximately half of new sexually transmitted infections (STIs) are diagnosed ...

How HIV researchers overcame setbacks and kept a vaccine trial going

Scientists say research into a vaccine for HIV is further along than it’s ever been.But Trump administration cuts to ...
C&EN

HIV can develop resistance to lenacapavir, but at a cost to the virus

Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...